Radar Therapeutics
The next frontier in medicine
- Headquarters
- Berkeley, California
- Employees
- 1–10
- Founded
- 2024
- Business Model
- B2B
- Website
- radartx.bio
- Total Funding
- $13.4M
- Last Round
- $13.4M SeedMay 2024
About
Radar Therapeutics is a Berkeley, California-based clinical-stage biotechnology company pioneering precision-expressed mRNA-based therapeutics. Founded in 2022 by synthetic biology pioneers Jim Collins, Eerik Kaseniit, and Xiaojing Gao, the company develops programmable mRNA medicines that activate only in the right cell type and at the right time, enabling highly specific genetic interventions for neurological diseases and aging-related conditions. The platform, which emerged from stealth in 2024 with $13.4M in seed funding, offers a new treatment modality distinct from conventional RNA interference or traditional mRNA delivery.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account